FEATURED BLOGS
Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as...
Feb 04, 2019
A recent study should serve as a wake-up call to all Americans that obesity is linked to an increased risk of common cancers.
Feb 01, 2019
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.
Feb 01, 2019
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Jan 29, 2019
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.

Advertisement

Latest Comments & Discussions


Ilkhomidin Karimovich Niyazov, PhD
Nov 08, 2018
Rest in peace!

Gouri Shankar Bhattacharyya, MD, PhD, MBBS, MNAMS, MRCP
Nov 08, 2018
"She lived every moment, She lived Beyond words She Left behind a legacy that makes GOODBYE hard. Stay Well Where ever you are, rest...

Jurema Telles O Lima, MD
Nov 08, 2018
we are deeply appalled by this early loss for all and for oncogeriatry. in the last ASCO I last saw her in the group of women oncologists...

David Michael Waterhouse, MD, MPH
Nov 07, 2018
My deepest sympathies to Arti's husband and daughter.  I was proveledged to work with Arti on ASCO's Clinical Research Committee...

Giridhar Santebennur, MD
Nov 07, 2018
Extremely saddened to hear tragic news about such an accomplished oncologist and researcher! My deepest sympathies to her...

Pages

Most Read

Clinical trials, a vital aspect of cancer research, can result in new, effective treatments that can help people with cancer live longer, healthier lives. So why is the participation so low?
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.

Tweets from ASCO

Tweets from Oncology Community